Association between Helicobacter pylori and mortality in the NHANES III study

Gut

Volumn 62, Issue 9, 2013, Pages 1262-1269

  Chen, Yu ^a   Segers, Stephanie ^a   Blaser, Martin J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CANCER MORTALITY; CANCER RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HELICOBACTER INFECTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER;

CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; GASTRIC CANCER; HELICOBACTER PYLORI; PANCREATIC CANCER;

ADOLESCENT; ADULT; AGE FACTORS; ANTIGENS, BACTERIAL; CAUSE OF DEATH; CHILD; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; STOMACH NEOPLASMS; STROKE; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84881549571     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303018     Document Type: Article

References (68)

1. Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007;445:915-18.
2. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
3. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
4. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994;120:977-81.
5. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71. (Pubitemid 24129959)
6. Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21. (Pubitemid 23178754)
7. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
8. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90. (Pubitemid 28099460)
9. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:388-96. (Pubitemid 38351300)
10. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005;191:761-7. (Pubitemid 40271067)
11. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52. (Pubitemid 44605589)
12. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007;167:821-7. (Pubitemid 46658341)
13. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008;198:553-60.
14. Mayr M, Kiechl S, Mendall MA, et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003;34:610-15. (Pubitemid 36307380)
15. Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxin-associated gene-A - positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-4. (Pubitemid 34827708)
16. Ridker PM, Danesh J, Youngman L, et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 2001;135:184-8. (Pubitemid 32738312)
17. Schottker B, Adamu MA, Weck MN, et al. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 2012;220:569-74.
18. Najafizadeh K, Falah Tafti S, Shiehmorteza M, et al. H pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2007;13:2349-51. (Pubitemid 46860737)
19. Philippou N, Koursarakos P, Anastasakou E, et al. Helicobacter pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2004;10:3342-4. (Pubitemid 39585479)
20. Behroozian R, Moradkhan E. The assessment of probable relationship between lung cancer and Helicobacter pylori infection. Trop Gastroenterol 2010;31:34-6.
21. Koshiol J, Flores R, Lam TK, et al. Helicobacter pylori seropositivity and risk of lung cancer. PloS one 2012;7:e32106.
22. Ece F, N FH, Erdal N, et al. Does Helicobacter pylori infection play a role in lung cancer? Respir Med 2005;99:1258-62. (Pubitemid 41245311)
23. Gocyk W, Niklinski T, Olechnowicz H, et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit 2000;6:1085-92. (Pubitemid 32009564)
24. Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359:931-5. (Pubitemid 34246383)
25. Kuipers EJ, Pena AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:328-31. (Pubitemid 23227561)
26. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-6. (Pubitemid 20008234)
27. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34. (Pubitemid 27379390)
28. Perez-Perez GI, Salomaa A, Kosunen TU, et al. Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut 2002;50:295-8. (Pubitemid 34161041)
29. Perez-Perez GI, Maw AM, Feingold-Link L, et al. Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens. J infect Dis 2010;202:916-23.
30. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 2006;103:732-7. (Pubitemid 43153094)
31. Andersson AF, Lindberg M, Jakobsson H, et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PloS one 2008;3:e2836.
32. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009;119:2475-87.
33. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004;4:688-94. (Pubitemid 39215067)
34. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-15.
35. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301. (Pubitemid 27145639)
36. Vaezi MF, Falk GW, Peek RM, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000;95:2206-11.
37. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7. (Pubitemid 28307287)
38. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Vital and Health Statistics, series 1, no. 32. Hyattsville, MD: National Center for Health Statistics, 2006.
39. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000;181:1359-63. (Pubitemid 30252540)
40. Thompson M. Aetiological factors in gastrointestinal carcinogenesis. Scand J Gastroenterol Suppl 1984;104:77-89. (Pubitemid 15191686)
41. Perez-Perez GI, Dworkin BM, Chodos JE, et al. Campylobacter pylori antibodies in humans. Ann Intern Med 1988;109:11-17.
42. Cho I, Blaser MJ, Francois F, et al. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005;162:579-84. (Pubitemid 41253256)
43. Romero-Gallo J, Perez-Perez GI, Novick RP, et al. Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens. Clin Diagn Lab Immunol 2002;9:1313-17. (Pubitemid 35283296)
44. Team DL. Comparative Analysis of the NHANES III Public-use and Restricted-use Linked Mortality Files: 2010 Public-use Data Release. Hyattsville, Maryland: National Center for Health Statistics.
45. NHANES III Mortality Follow-Up. National Center for Health Statistics Center for Disease Control and Prevention. http://www.cdc.gov/nchs/data-access/ data-linkage/mortality/nhanes3-linkage.htm. 2010. (accessed 11 Dec 2012)
46. Ziebarth D, Spiegelhalder B, Bartsch H. N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Carcinogenesis 1997;18:383-9. (Pubitemid 28132433)
47. Third National Health and Nutrition Examination Survey (NHANES III), 1988-94, NHANES III Household Adult Data File Documentation, Ages 17+. 1996.
48. Cheng TY, Neuhouser ML. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction. Cancer Causes Control 2012;23:1557-65.
49. Lazo M, Hernaez R, Bonekamp S, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011;343:d6891.
50. Yang Q, Bailey L, Clarke R, et al. Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr 2012;95:1245-53.
51. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 1995;57:289-300.
52. Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009;202:535-42.
53. Zhang S, Guo Y, Ma Y, et al. Relationship between the cytotoxin-associated gene-A status of H pylori strains and cerebral infarction in European Caucasians and Chinese Han: a meta-analysis. World J Gastroenterol 2008;14:1286-92. (Pubitemid 351356341)
54. Yang X, Gao Y, Zhao X, et al. Chronic Helicobacter pylori infection and ischemic stroke subtypes. Neurol Res 2011;33:467-72.
55. Haider AW, Wilson PW, Larson MG, et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002;40:1408-13. (Pubitemid 35192864)
56. Smieja M, Gnarpe J, Lonn E, et al. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003;107:251-7. (Pubitemid 36135220)
57. Elkind MS, Ramakrishnan P, Moon YP, et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol 2010;67:33-8.
58. Strandberg TE, Tilvis RS, Vuoristo M, et al. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997;314:1317-18. (Pubitemid 27183319)
59. Strachan DP, Mendall MA, Carrington D, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation 1998;98:1286-90. (Pubitemid 28443391)
60. Heuschmann PU, Neureiter D, Gesslein M, et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke 2001;32:2253-8. (Pubitemid 32954790)
61. Planas AM, Chamorro A. Regulatory T cells protect the brain after stroke. Nat Med 2009;15:138-9.
62. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009;15:192-9.
63. Robinson K, Kenefeck R, Pidgeon EL, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008;57:1375-85.
64. Arnold IC, Dehzad N, Reuter S, et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011;121:3088-93.
65. Oertli M, Sundquist M, Hitzler I, et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012;122:1082-96.
66. Iso H, Jacobs DR Jr, Goldman L. Accuracy of death certificate diagnosis of intracranial hemorrhage and nonhemorrhagic stroke. The Minnesota Heart Survey. Am J Epidemiol 1990;132:993-8. (Pubitemid 20363678)
67. Corwin LE, Wolf PA, Kannel WB, et al. Accuracy of death certification of stroke: the Framingham Study. Stroke 1982;13:818-21. (Pubitemid 13251494)
68. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009;7:887-94.